Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 30, 2022

Efficacy of Fourth Dose of the BNT162b2 Vaccine Among Older Adults in Israel

The New England Journal of Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

The New England Journal of Medicine
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
N. Engl. J. Med 2022 Apr 13;[EPub Ahead of Print], O Magen, JG Waxman, M Makov-Assif, R Vered, D Dicker, MA Hernán, M Lipsitch, BY Reis, RD Balicer, N Dagan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading